Johannes M Hennings

Summary

Publications

  1. doi Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - findings from the Munich Antidepressant Response Signature (MARS) project
    Johannes M Hennings
    Max Planck Institute of Psychiatry, Kraepelinstr 2 10, 80804 Munich, Germany
    J Psychiatr Res 43:215-29. 2009
  2. pmc Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatment
    Sonja Horstmann
    Max Planck Institute of Psychiatry, Munich, Germany
    Neuropsychopharmacology 35:727-40. 2010
  3. doi A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression
    Marcus Ising
    Max Planck Institute of Psychiatry, Munich 80804, Germany
    Arch Gen Psychiatry 66:966-75. 2009
  4. ncbi Glucose metabolism and antidepressant medication
    Johannes M Hennings
    Max Planck Institute of Psychiatry, Psychiatric Pharmacogenetics, Munich, Germany
    Curr Pharm Des 18:5900-19. 2012
  5. pmc Possible associations of NTRK2 polymorphisms with antidepressant treatment outcome: findings from an extended tag SNP approach
    Johannes M Hennings
    Max Planck Institute of Psychiatry, Munich, Germany
    PLoS ONE 8:e64947. 2013

Detail Information

Publications5

  1. doi Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - findings from the Munich Antidepressant Response Signature (MARS) project
    Johannes M Hennings
    Max Planck Institute of Psychiatry, Kraepelinstr 2 10, 80804 Munich, Germany
    J Psychiatr Res 43:215-29. 2009
    ..We demonstrated that this subgroup can be characterized by a set of demographic, clinical and neuroendocrine variables allowing to predict unfavorable outcome at an early stage of treatment...
  2. pmc Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatment
    Sonja Horstmann
    Max Planck Institute of Psychiatry, Munich, Germany
    Neuropsychopharmacology 35:727-40. 2010
    ....
  3. doi A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression
    Marcus Ising
    Max Planck Institute of Psychiatry, Munich 80804, Germany
    Arch Gen Psychiatry 66:966-75. 2009
    ..Genetic factors and clinical characteristics contribute to the failure of a favorable treatment outcome...
  4. ncbi Glucose metabolism and antidepressant medication
    Johannes M Hennings
    Max Planck Institute of Psychiatry, Psychiatric Pharmacogenetics, Munich, Germany
    Curr Pharm Des 18:5900-19. 2012
    ..The synthesis of the findings is discussed in light of the specific pharmacodynamic properties of the antidepressants as well as the pathophysiological changes in depression and impaired glucose homeostasis, including animal studies...
  5. pmc Possible associations of NTRK2 polymorphisms with antidepressant treatment outcome: findings from an extended tag SNP approach
    Johannes M Hennings
    Max Planck Institute of Psychiatry, Munich, Germany
    PLoS ONE 8:e64947. 2013
    ..Genetic variations within the genes coding for the brain-derived neurotrophic factor (BDNF) and its key receptor Trkb (NTRK2) may therefore influence the response to antidepressant treatment...